Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2025-12-24 @ 3:42 PM
NCT ID:
NCT00918892
Eligibility Criteria:
Inclusion Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of breast cancer
* Tissue samples available
* Samples are selected based on presence or absence of tumor receptors, (i.e.; estrogen, progesterone, and HER2 receptors) and grouped into following 4 categories:
* Estrogen receptor (ER)-positive/progesterone receptor (PR)-positive/HER2-negative
* ER-positive/PR-positive/ HER2-positive by FISH
* ER-negative/PR-negative/HER2-positive
* ER-negative/PR-negative/HER2-negative(triple negative or basal-type cancers)
PATIENT CHARACTERISTICS:
* Menopausal status not specified
PRIOR CONCURRENT THERAPY:
* Not specified
Exclusion Criteria:
* There are no exclusion criteria in this protocol
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00918892
Study Brief:
Protocol Section:
NCT00918892